Difference between revisions of "Pelvic exenteration"
From WikiAnesthesia
Nirav Kamdar (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox surgical procedure | {{Infobox surgical procedure | ||
| anesthesia_type = | | anesthesia_type = General | ||
| airway = | | airway = ETT | ||
| lines_access = | | lines_access = 2-3 Large bore IVs, Arterial line | ||
| monitors = | | monitors = Standard | ||
| considerations_preoperative = | | considerations_preoperative = | ||
| considerations_intraoperative = | | considerations_intraoperative = Volume shifts and bleeding | ||
| considerations_postoperative = | | considerations_postoperative = | ||
}} | }} | ||
Pelvic exenteration is a large abdominal surgery utilized in treating advanced or recurrent pelvic carcinoma where all pelvic tissues, including the cervix, bladder, lymph nodes, rectum, uterus, and vagina, are resected along with vaginal reconstruction and colon and urinary diversions. | |||
== Preoperative management == | == Preoperative management == | ||
| Line 25: | Line 25: | ||
| | | | ||
|- | |- | ||
| | |Pulmonary | ||
| | | | ||
|- | |- | ||
| Line 45: | Line 45: | ||
=== Labs and studies<!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --> === | === Labs and studies<!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --> === | ||
Extend of tumor burden, vascular involvement of masses | |||
=== Operating room setup<!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --> === | === Operating room setup<!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --> === | ||
| Line 67: | Line 68: | ||
=== Disposition<!-- List and/or describe the postoperative disposition and any special considerations for transport of patients for this case. --> === | === Disposition<!-- List and/or describe the postoperative disposition and any special considerations for transport of patients for this case. --> === | ||
ICU | |||
=== Pain management<!-- Describe the expected level of postoperative pain and approaches to pain management for this case. --> === | === Pain management<!-- Describe the expected level of postoperative pain and approaches to pain management for this case. --> === | ||
Latest revision as of 00:33, 30 May 2022
Pelvic exenteration
| Anesthesia type |
General |
|---|---|
| Airway |
ETT |
| Lines and access |
2-3 Large bore IVs, Arterial line |
| Monitors |
Standard |
| Primary anesthetic considerations | |
| Preoperative | |
| Intraoperative |
Volume shifts and bleeding |
| Postoperative | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Pelvic exenteration is a large abdominal surgery utilized in treating advanced or recurrent pelvic carcinoma where all pelvic tissues, including the cervix, bladder, lymph nodes, rectum, uterus, and vagina, are resected along with vaginal reconstruction and colon and urinary diversions.
Preoperative management
Patient evaluation
| System | Considerations |
|---|---|
| Neurologic | |
| Cardiovascular | |
| Pulmonary | |
| Gastrointestinal | |
| Hematologic | |
| Renal | |
| Endocrine | |
| Other |
Labs and studies
Extend of tumor burden, vascular involvement of masses
Operating room setup
Patient preparation and premedication
Regional and neuraxial techniques
Intraoperative management
Monitoring and access
Induction and airway management
Positioning
Maintenance and surgical considerations
Emergence
Postoperative management
Disposition
ICU
Pain management
Potential complications
Procedure variants
| Variant 1 | Variant 2 | |
|---|---|---|
| Unique considerations | ||
| Position | ||
| Surgical time | ||
| EBL | ||
| Postoperative disposition | ||
| Pain management | ||
| Potential complications |
References
Top contributors: Nirav Kamdar, Mitchel DeVita and Chris Rishel